This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal

ESMO 2024 Shorts Series

Insights from leading oncologists on topics in prostate cancer treatment

ESMO 2024 Banner

Welcome to our dedicated

ESMO 2024
Shorts Series, where we present exclusive insights from leading oncologists on topics in prostate cancer treatment, filmed at the European Society of Medical Oncology Annual Congress in Barcelona 2024.

 

Featuring:

  • Part ONE | ESMO talks 2024: Let's discuss a complex mHSPC patient case study
    • With Dr. Mark Prentice
      (Consultant Clinical Oncologist, Royal Free Hospital NHS Foundation Trust)
  • Part TWO | ESMO talks 2024: The RECORD study + anticoagulants DDI subanalysis
    • With Prof. Amit Bahl
       (Consultant Clinical Oncologist, University Hospitals Bristol and Chair of the British Uro-Oncology Group)

ESMO talks 2024: Let's discuss a complex mHSPC patient case study - with Dr. Mark Prentice

Delve into a complex metastatic hormone-sensitive prostate cancer (mHSPC) case study with Dr Mark Prentice. hear insights about his treatment approaches, and key considerations in selecting the appropriate patient for treatment.

NUBEQA Prescribing Information

Speakers

Stay updated & develop your learning profile

Join the BayerPro HCP learning community

Register Here

Abbreviation:
DDI
; drug-drug-intereactions

 

PP-NUB-GB-2082 | January 2025